NCT03961906

Brief Summary

Goal of this study is to develop and evaluate a physiotherapy concept that is focused on bilateral leg spasticity and aims to reduce spastic gait disturbance and to improve mobility in patients suffering from HSP.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
53

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Jan 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2017

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

May 20, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 23, 2019

Completed
Last Updated

May 23, 2019

Status Verified

May 1, 2019

Enrollment Period

2.2 years

First QC Date

May 20, 2019

Last Update Submit

May 22, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in total Spastic paraplegia rating scale (SPRS) score

    Change in the total SPRS score (see references for publication) (range 0-52 points, higher points indicated stronger disease severity) will be evaluated at two timepoints compared to baseline (12 weeks as short-term measure and 26 weeks as long-term measure).

    12 weeks and 26 weeks

Secondary Outcomes (1)

  • Change in Three Minute Walk

    12 weeks and 26 weeks

Study Arms (2)

Tübingen physiotherapy concept

ACTIVE COMPARATOR

Will receive our therapy concept and perform self-trainings on a regular basis.

Behavioral: physiotherapy

controls

NO INTERVENTION

Will receive standard-care which includes their regular physiotherapy as provided by the local therapist and can include self-trainings as well.

Interventions

physiotherapyBEHAVIORAL

Will receive two trainings. First training in week one after baseline assessment for three consecutive days 60 min twice daily by trained physiotherapists and in week three further two days with 60min once daily.

Tübingen physiotherapy concept

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • clinical diagnosis of hereditary spastic paraplegia
  • manifest spastic gait disturbance
  • remaining walking ability of at least 100m in three minutes,
  • no functional electronic stimulation during the study period.

You may not qualify if:

  • see above

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Tübingen, Center for Neurology

Tübingen, 72076, Germany

Location

Related Publications (1)

  • Schule R, Holland-Letz T, Klimpe S, Kassubek J, Klopstock T, Mall V, Otto S, Winner B, Schols L. The Spastic Paraplegia Rating Scale (SPRS): a reliable and valid measure of disease severity. Neurology. 2006 Aug 8;67(3):430-4. doi: 10.1212/01.wnl.0000228242.53336.90.

    PMID: 16894103BACKGROUND

MeSH Terms

Conditions

Spastic Paraplegia, Hereditary

Interventions

Physical Therapy Modalities

Condition Hierarchy (Ancestors)

Hereditary Sensory and Motor NeuropathyNervous System MalformationsNervous System DiseasesHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesPolyneuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGenetic Diseases, Inborn

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitation

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Masking only for baseline visit.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 20, 2019

First Posted

May 23, 2019

Study Start

January 1, 2015

Primary Completion

March 30, 2017

Study Completion

March 30, 2017

Last Updated

May 23, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Available upon request

Locations